Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alejandro Gonzalez Della Valle

Orthopaedic Surgery New York, NY Medical Doctor

NPI 1659389153 CMS profile 257095

535 E 70Th St, New York, NY 10021

Open in the dashboard

General payments

$334,140

258 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$124,950

1 holding reported · through program year 2025

Research they led as principal investigator

$28,580 paid to institutions, not to them · program year 2020

Through program year 2025, Alejandro Gonzalez Della Valle of New York, NY is reported in the CMS Open Payments database as having received $334,140 across 258 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $28,580 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $124,950 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $68,126 57
2024 General $71,525 62
2023 General $51,953 31
2022 General $23,188 25
2021 General $36,085 34
2020 General $10,925 14
2019 General $72,337 35
2025 Ownership $124,950 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alejandro Gonzalez Della Valle
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Alejandro Gonzalez Della Valle were reported at $68,126. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Alejandro Gonzalez Della Valle Orthopaedic Surgery median Middle half National median
2019 $72,337 $644 $140–$2,844 $163
2020 $10,925 $312 $75–$1,860 $114
2021 $36,085 $520 $117–$2,495 $132
2022 $23,188 $598 $128–$2,731 $149
2023 $51,953 $461 $128–$2,264 $160
2024 $71,525 $497 $134–$2,475 $164
2025 $68,126 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ortho Development Corporation $95,077 94 payments
  2. LinkBio Corp $45,648 22 payments
  3. OrthoSensor Inc. $44,992 5 payments
  4. MicroPort Orthopedics Inc $42,234 33 payments
  5. Encore Medical, LP $35,998 34 payments
  6. Naviswiss, Inc. $33,241 24 payments
  7. Medical Device Business Services, Inc. $17,859 12 payments
  8. Stryker Corporation $8,672 11 payments
  9. Intellijoint Surgical Inc. $5,056 2 payments
  10. Smith+Nephew, Inc. $3,658 1 payment
  11. Other $1,706 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $168,700 71 payments
  2. Royalty or License $142,040 102 payments
  3. Travel and Lodging $16,669 25 payments
  4. Food and Beverage $6,713 59 payments
  5. Education $18 1 payment
Products named General payments · program years 2019–2025
  1. Alpine Hip System $75,662 66 payments
  2. Verasense Orthopedics $44,992 5 payments
  3. MPO Medial Pivot Knee $42,234 33 payments
  4. Alpine $17,397 24 payments
  5. Naviswiss Knee Navigation $16,515 8 payments
  6. Naviswiss Hip/Knee Navigation $13,010 12 payments
  7. DJO SURGICAL $12,941 12 payments
  8. PINNACLE $11,512 5 payments
  9. RECLAIM $11,512 5 payments
  10. VERASENSE Joint Replacement Hips, Knees $7,923 10 payments
  11. Other $58,545 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

57

Median for Orthopaedic Surgery: 30

Drug cost

$440

Median for Orthopaedic Surgery: $176

Branded share of claims

0%

Median for Orthopaedic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 16 $330
Amoxicillin Generic 21 $66
Meloxicam Generic 20 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.

Records

258 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record